{"id":61272,"date":"2025-05-16T22:02:33","date_gmt":"2025-05-16T20:02:33","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\/"},"modified":"2025-05-16T22:02:33","modified_gmt":"2025-05-16T20:02:33","slug":"liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\/","title":{"rendered":"Liberate Bio Announces Presentation to Update on RAPTOR LNP Platform and CAR-M Therapeutic Programs"},"content":{"rendered":"
\n

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Liberate Bio, Inc., a biotechnology company developing medicines which efficiently and selectively deliver payloads to immune cells while bypassing the live, announced an oral presentation by Melissa Deck – Director of Platform, demonstrating the success of Liberate\u2019s RAPTOR\u2122 screening platform and NHP data for the company\u2019s first lead candidates at the Oligonucleotide and Peptide Therapeutics 2025 (TIDES) being held May 19th-22nd, 2025 in San Diego, California.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\n\u201cWe built the RAPTOR platform to address key limitations of existing delivery vehicles and to expand the potential of oligonucleotide therapeutics beyond the liver. We are thrilled to have reached this critical inflection point,\u201d said Walter R. Strapps, Ph.D., Chief Scientific Officer of Liberate. \u201cThe presentation shows that our lead lipids robustly deliver mRNA cargo to monocytes and macrophages in non-human primates. This has enabled our first therapeutic program, in vivo<\/i> CAR-M to treat solid tumors.\u201d\n<\/p>\n

\nKey Highlights from the Presentation:\n<\/p>\n

\nLiberate Bio has built RAPTOR\u2122, a robust nanoparticle screening platform for evaluating and identifying extrahepatic delivery vehicles directly in non-human primates (NHPs). RAPTOR\u2122 has generated lipid nanoparticles (LNPs) with significant delivery to bone marrow and expression of mRNA cargo in monocytes, macrophages and other cell-types relevant to in vivo CAR therapy. At the same time, Liberate\u2019s lead candidates show a five -old reduction in liver accumulation of cargo.\n<\/p>\n

\nTIDES Presentation Details:\n<\/p>\n

\nTITLE: \u201cInnovating Nucleic Acid Delivery: RAPTOR, Artificial Intelligence, and the Future of CAR-M\u201d\n<\/p>\n

\nSESSION TITLE: Delivery of Macromolecules\n<\/p>\n

\nPRESENTATION TYPE: Oral\n<\/p>\n

\nPRESENTER: Melissa K. Deck, Director of Platform, Liberate Bio.\n<\/p>\n

\nDATE AND TIME: Wednesday, 21 May, 10:45am PT\n<\/p>\n

\nAbout Liberate Bio\n<\/p>\n

\nOur vision at Liberate Bio is to achieve the extraordinary\u2014delivering genetic medicines that transcend liver-based limitations, liberating patients from disease. Today\u2019s genetic medicines are limited by the availability of safe, effective delivery vehicles that direct nucleic acid therapeutics to any organ other than the liver. To realize the full potential of genetic medicines, we use our proprietary screening platform to rapidly evaluate rational and artificial intelligence-designed nanoparticles, reducing the cycle time for identifying novel vehicles from years to months. Our initial lead candidates are allowing us to pursue multiple therapeutic areas based on delivery to various bone marrow derived cells including HSCs, monocytes and macrophages. We have built the team and a suite of tools that allows us to rapidly move RNA therapeutics to the clinic by significantly increasing the translatability of the preclinical work.\n<\/p>\n

\nFor more information about the company\u2019s technologies, team, and mission, visit www.liberatebio.com<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nWalter Strapps, CSO
\n
wstrapps@liberatebio.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Liberate Bio, Inc., a biotechnology company developing medicines which efficiently and selectively deliver payloads to immune cells while bypassing the live, announced an oral presentation by Melissa Deck – Director of Platform, demonstrating the success of Liberate\u2019s RAPTOR\u2122 screening platform and NHP data for the company\u2019s first lead candidates at the Oligonucleotide and … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61272","6":"format-standard","7":"category-industry"},"yoast_head":"\nLiberate Bio Announces Presentation to Update on RAPTOR LNP Platform and CAR-M Therapeutic Programs - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Liberate Bio Announces Presentation to Update on RAPTOR LNP Platform and CAR-M Therapeutic Programs - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass.–(BUSINESS WIRE)–Liberate Bio, Inc., a biotechnology company developing medicines which efficiently and selectively deliver payloads to immune cells while bypassing the live, announced an oral presentation by Melissa Deck – Director of Platform, demonstrating the success of Liberate\u2019s RAPTOR\u2122 screening platform and NHP data for the company\u2019s first lead candidates at the Oligonucleotide and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-16T20:02:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250516521975\/en\/2471148\/22\/Liberate_Bio_Logo_Horizontal-2color.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Liberate Bio Announces Presentation to Update on RAPTOR LNP Platform and CAR-M Therapeutic Programs\",\"datePublished\":\"2025-05-16T20:02:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\\\/\"},\"wordCount\":439,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250516521975\\\/en\\\/2471148\\\/22\\\/Liberate_Bio_Logo_Horizontal-2color.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\\\/\",\"name\":\"Liberate Bio Announces Presentation to Update on RAPTOR LNP Platform and CAR-M Therapeutic Programs - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250516521975\\\/en\\\/2471148\\\/22\\\/Liberate_Bio_Logo_Horizontal-2color.jpg\",\"datePublished\":\"2025-05-16T20:02:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250516521975\\\/en\\\/2471148\\\/22\\\/Liberate_Bio_Logo_Horizontal-2color.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250516521975\\\/en\\\/2471148\\\/22\\\/Liberate_Bio_Logo_Horizontal-2color.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Liberate Bio Announces Presentation to Update on RAPTOR LNP Platform and CAR-M Therapeutic Programs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Liberate Bio Announces Presentation to Update on RAPTOR LNP Platform and CAR-M Therapeutic Programs - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\/","og_locale":"en_US","og_type":"article","og_title":"Liberate Bio Announces Presentation to Update on RAPTOR LNP Platform and CAR-M Therapeutic Programs - Pharma Trend","og_description":"CAMBRIDGE, Mass.–(BUSINESS WIRE)–Liberate Bio, Inc., a biotechnology company developing medicines which efficiently and selectively deliver payloads to immune cells while bypassing the live, announced an oral presentation by Melissa Deck – Director of Platform, demonstrating the success of Liberate\u2019s RAPTOR\u2122 screening platform and NHP data for the company\u2019s first lead candidates at the Oligonucleotide and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\/","og_site_name":"Pharma Trend","article_published_time":"2025-05-16T20:02:33+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250516521975\/en\/2471148\/22\/Liberate_Bio_Logo_Horizontal-2color.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Liberate Bio Announces Presentation to Update on RAPTOR LNP Platform and CAR-M Therapeutic Programs","datePublished":"2025-05-16T20:02:33+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\/"},"wordCount":439,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250516521975\/en\/2471148\/22\/Liberate_Bio_Logo_Horizontal-2color.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\/","url":"https:\/\/pharma-trend.com\/en\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\/","name":"Liberate Bio Announces Presentation to Update on RAPTOR LNP Platform and CAR-M Therapeutic Programs - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250516521975\/en\/2471148\/22\/Liberate_Bio_Logo_Horizontal-2color.jpg","datePublished":"2025-05-16T20:02:33+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250516521975\/en\/2471148\/22\/Liberate_Bio_Logo_Horizontal-2color.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250516521975\/en\/2471148\/22\/Liberate_Bio_Logo_Horizontal-2color.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/liberate-bio-announces-presentation-to-update-on-raptor-lnp-platform-and-car-m-therapeutic-programs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Liberate Bio Announces Presentation to Update on RAPTOR LNP Platform and CAR-M Therapeutic Programs"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61272","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61272"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61272\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61272"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61272"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61272"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}